Log in to search using one of your social media accounts:

 

Hormone Therapy May Improve Schizophrenia Outcomes Hormone Therapy May Improve Schizophrenia Outcomes
A selective estrogen receptor modulator improves outcomes in men and women with schizophrenia when added to treatment with an antipsychotic.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 22, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Hormone therapy linked to lower curvature of the spine
A study in the journalMenopausesuggests that hormone therapy may help reduce hyperkyphosis in women. Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 21, 2018 Category: Endocrinology Source Type: news

New study suggests hormone therapy helps reduce curvature of the spine
(The North American Menopause Society (NAMS)) The Women's Health Initiative found that hormone therapy (HT) use was associated with a reduction in vertebral fracture risk. A new study shows these same benefits may also guard against a woman's risk of developing hyperkyphosis, an exaggerated curvature of the spine that creates a forward stooped posture. Study results are published online today in Menopause, the journal of The North American Menopause Society. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 21, 2018 Category: International Medicine & Public Health Source Type: news

New Treatment Approved for Prostate Cancer That Resists Hormone Therapy
Title: New Treatment Approved for Prostate Cancer That Resists Hormone TherapyCategory: Health NewsCreated: 2/14/2018 12:00:00 AMLast Editorial Review: 2/15/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 15, 2018 Category: Cancer & Oncology Source Type: news

How a transgender woman breast-fed her baby
She told doctors that she wanted to breast-feed her baby. She explained that her partner was pregnant but was not planning to breast-feed when the child was born, so she wanted to take it on herself. The 30-year-old, who is transgender, was willing to accept the risks. Following months of hormone therapy last year, doctors say she might be the first reported transgender woman in […]Related:An American says she fell asleep with a headache — and woke up with a British accentShe thought the weird sensation was a stray eyelash. It was eye worms.Here’s what yo...
Source: Washington Post: To Your Health - February 14, 2018 Category: Consumer Health News Source Type: news

FDA approves J & J prostate cancer treatment
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Johnson& Johnson's Erleada treatment for use with prostate cancer patients whose cancer has not spread but continues to grow despite hormone therapy. (Source: Reuters: Health)
Source: Reuters: Health - February 14, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

New Treatment Apalutamide (Erleada) Approved for Prostate Cancer That Resists Hormone Therapy
WEDNESDAY, Feb. 14, 2018 -- Erleada (apalutamide) has been approved by the U.S. Food and Drug Administration to treat non-spreading prostate cancer that continues to grow despite hormone therapy. Prostate cancer is the second-most-common form of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2018 Category: General Medicine Source Type: news

New Treatment Approved for Prostate Cancer That Resists Hormone Therapy
WEDNESDAY, Feb. 14, 2018 -- Erleada (apalutamide) has been approved by the U.S. Food and Drug Administration to treat non-spreading prostate cancer that continues to grow despite hormone therapy. Prostate cancer is the second-most-common form of the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 14, 2018 Category: General Medicine Source Type: news

NAMS: The 2017 Hormone Therapy Position Statement NAMS: The 2017 Hormone Therapy Position Statement
A panel of clinicians and researchers expert in the field of women's health and menopause has revised the NAMS 2012 Position Statement with updated recommendations and areas for future research.The North American Menopause Society (NAMS) (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 8, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Pfizer's Xtandi delays prostate cancer spread in early stage disease
(Reuters) - Use of Xtandi in early stage prostate cancer on top of standard hormone therapy reduced the risk of disease spreading or death by 71 percent compared with hormone therapy alone, study results that could lead to significantly increased sales of the Pfizer Inc and Astellas Pharma Inc medicine. (Source: Reuters: Health)
Source: Reuters: Health - February 5, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Can HRT Relieve Migraines in Symptomatic Women? Can HRT Relieve Migraines in Symptomatic Women?
New research explores the risk/benefit profile of reproductive hormone therapy in menopausal women with migraine.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 18, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Commentary Source Type: news

Hormone therapy, gender affirmation surgery, and their association with recent suicidal ideation and depression symptoms in transgender veterans - Tucker RP, Testa RJ, Simpson TL, Shipherd JC, Blosnich JR, Lehavot K.
BACKGROUND: Access to transition-related medical interventions (TRMIs) for transgender veterans has been the subject of substantial public interest and debate. To better inform these important conversations, the current study investigated whether undergoin... (Source: SafetyLit)
Source: SafetyLit - January 17, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Hormone Therapy May Head Off Menopausal Depression Hormone Therapy May Head Off Menopausal Depression
Hormone therapy may help prevent the onset of symptoms of depression in the transition to menopause, particularly for women experiencing recent life stressors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 11, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Hormone Therapy May Ease Depression Linked to Menopause
Title: Hormone Therapy May Ease Depression Linked to MenopauseCategory: Health NewsCreated: 1/10/2018 12:00:00 AMLast Editorial Review: 1/11/2018 12:00:00 AM (Source: MedicineNet Menopause General)
Source: MedicineNet Menopause General - January 11, 2018 Category: Primary Care Source Type: news

Hormone Therapy Appears to Reduce Depression Risk in Perimenopausal Women
Transdermal estrogen combined with oral progesterone lowers the risk for depression in perimenopausal women, suggests a small trial in JAMA Psychiatry. Some 170 nondepressed perimenopausal... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - January 11, 2018 Category: Primary Care Source Type: news

Hormone therapy may reduce eating disorder symptoms in transgender people
(University of Nottingham) New research has shown that receiving cross-sex hormone therapy (CHT) can help to reduce the feelings of body dissatisfaction associated with eating disorders including anorexia and bulimia in transgender people. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 11, 2018 Category: International Medicine & Public Health Source Type: news

Hormone therapy stops depression before menopause starts
Women going through menopause are twice as likely to experience depression. Researchers from the University of North Carolina found that hormone therapy can prevent it. (Source: the Mail online | Health)
Source: the Mail online | Health - January 10, 2018 Category: Consumer Health News Source Type: news

Hormone Therapy May Aid Menopausal Depression
Surprisingly, for women with a past history of major depression -- which is a known risk factor for future depression -- hormone therapy didn't appear to lessen the risk of depressive symptoms. (Source: WebMD Health)
Source: WebMD Health - January 10, 2018 Category: Consumer Health News Source Type: news

Hormone Therapy May Ease Depression Linked to Menopause
WEDNESDAY, Jan. 10, 2018 -- A year of hormone therapy cut the risk of depression symptoms in women going through menopause and early postmenopause, new research shows. " Thirty-two percent of women randomized to treatment with a placebo experienced... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 10, 2018 Category: General Medicine Source Type: news

Hot flashes in hormone-treated cancer patients can be managed
According to a study, published inJAMA, hot flashes caused by hormone therapy in cancer patients can be medically managed to reduce discomfort of patients.Reuters (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 10, 2018 Category: Endocrinology Source Type: news

Hot flashes caused by cancer therapy can be prevented, treated
(Reuters Health) - Cancer patients with hot flashes related to hormone therapy should know that these uncomfortable symptoms can be managed, according to a recently published resource for patients. (Source: Reuters: Health)
Source: Reuters: Health - January 8, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Hormone Therapy and Chronic Conditions: Let's Get Rational Hormone Therapy and Chronic Conditions: Let's Get Rational
Hormone therapy must be discussed and individualized for each patient in order to achieve the best outcome for treating menopause.Medscape Ob/Gyn (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 4, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Commentary Source Type: news

Hormone therapy found to reduce weight gain with low cancer risk
According to a study, published inPLOS One, combination therapy of conjugated estrogens with bazedoxifene can improve metabolic function, whilst avoiding an increased risk of reproductive cancer, in a mouse model.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 2, 2018 Category: Endocrinology Source Type: news

Hormone Therapy Remains a'Flash Point' for Controversy
(MedPage Today) -- NAMS urges clinicians to have'evidence based discussions'with patients (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - December 29, 2017 Category: Endocrinology Source Type: news

TherapeuticsMD submits NDA for hormone therapy to treat vasomotor symptoms
TherapeuticsMD (NSDQ:TXMD) has submitted its bio-identical hormone therapy to the FDA for approval as a treatment for moderate-to-severe vasomotor symptoms due to menopause. The company’s investigational combination of estradiol and progesterone is delivered in a single, oral soft-gel capsule. Get the full story at our sister site, Drug Delivery Business News. The post TherapeuticsMD submits NDA for hormone therapy to treat vasomotor symptoms appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - December 29, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Gynecological Pharmaceuticals Wall Street Beat Women's Health TherapeuticsMD Source Type: news

Restarting Adjuvant Hormone Therapy in Breast Cancer Restarting Adjuvant Hormone Therapy in Breast Cancer
Do women with breast cancer have better outcomes after restarting adjuvant hormone therapy that had been temporarily stopped?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 26, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Hormone therapy combination may benefit health without increasing cancer risk
(University of Illinois at Urbana-Champaign) A team led by University of Illinois food science and human nutrition professor Zeynep Madak-Erdogan found that treating ovariectomized mice with a combination of conjugated estrogens and the drug bazedoxifene improved metabolism and prevented the weight gain often associated with low estrogen levels without posing increased risk to their reproductive tissues. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 22, 2017 Category: Cancer & Oncology Source Type: news

Hormonal Therapy in Advanced Endometrial Cancer Hormonal Therapy in Advanced Endometrial Cancer
This meta-analysis may finally clarify which patients are most likely to respond to hormonal therapy.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 15, 2017 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Artificial ovaries could replace hormone therapy
Researchers with the Wake Forest Institute for Regenerative Medicine have found that bioengineered ovaries are more effective than hormone therapy drugs at improving bone and uterine health.   The researchers are looking into the artificial ovaries as an alternative to hormone replacement medications, which work to help with the loss of female sex hormone production. Loss of ovarian function can affect the genital and urinary system, including urinary incontinence, among other issues.   The researchers… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 14, 2017 Category: Biotechnology Authors: Jessica Seaman Source Type: news

Wake Forest study: Lab-engineered ovaries could be better than hormone therapy
Researchers with the Wake Forest Institute for Regenerative Medicine have found that bioengineered ovaries are more effective than hormone therapy drugs at improving bone and uterine health, along with body composition in rats.   The researchers are looking into the artificial ovaries as an alternative to hormone replacement medications, which work to help with the loss of female sex hormone production. Loss of ovarian function can affect the genital and urinary system, including urinary incontinence,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 14, 2017 Category: Pharmaceuticals Authors: Jessica Seaman Source Type: news

USPSTF Finalizes Recommendations Against Hormone Therapy for Preventing Chronic Conditions
The U.S. Preventive Services Task Force has finalized its recommendations against hormone therapy for preventing chronic conditions in postmenopausal women. The grade D recommendations, published... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 14, 2017 Category: Primary Care Source Type: news

Will New Postmenopausal Hormone Therapy Recommendation Scare Off Women Who Need It For Hot Flashes?
Relatively few women use postmenopausal hormone therapy nowadays to stave off diseases as they age. So will a respected panel's new recommendation against its use for that purpose lead to undertreatment of hot flashes and night sweats? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 13, 2017 Category: Pharmaceuticals Authors: Rita Rubin, Contributor Tags: NYSE:PFE Source Type: news

Will Postmenopausal Hormone Therapy Recommendation Scare Off Women Who Need It For Hot Flashes?
Relatively few women use postmenopausal hormone therapy nowadays to stave off diseases as they age. So will a respected panel's new recommendation against its use for that purpose lead to undertreatment of hot flashes and night sweats? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 13, 2017 Category: Pharmaceuticals Authors: Rita Rubin, Contributor Tags: NYSE:PFE Source Type: news

Older women should not take hormones to prevent chronic diseases
(Reuters Health) - Postmenopausal women should not use hormone therapy to prevent chronic medical conditions, because the risk of significant side effects outweighs the unclear evidence of a benefit, according to a government-backed panel of experts. (Source: Reuters: Health)
Source: Reuters: Health - December 12, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Makayla ’s story: Living with Leri-Weill Dyschondrosteosis
Our daughter Makayla was born perfectly healthy on April 5th, 2014, passing all of the usual newborn screenings without issue. From day one, her personality shone through. She was strong-willed and had a smile that would light up her eyes before her mouth even showed a hint of joy. But over the next 3 months, Makayla wasn’t eating well and wasn’t gaining enough weight.  Our pediatrician referred us to Dr. Elizabeth Hait, a gastroenterologist at Boston Children’s Hospital. Dr. Hait would change Makayla’s formula multiple times and put her on medication for her acid reflux. Her pediatrician also ...
Source: Thrive, Children's Hospital Boston - December 12, 2017 Category: Pediatrics Authors: Kerri Theriault Tags: Our Patients’ Stories Division of Endocrinology Dr. James Kasser Dr. Travis Matheney hip dysplasia Orthopedic Center Otolaryngology Department Source Type: news

Fewer Hormonal Meds for Breast Cancer Patients?
Women with earlier-stage breast cancer may be able to spend less time on hormonal therapy without dimming their prognosis, a new study suggests. (Source: WebMD Health)
Source: WebMD Health - December 8, 2017 Category: Consumer Health News Source Type: news

For Breast Cancer Patients, Less Time on Hormonal Meds?
THURSDAY, Dec. 7, 2017 -- Women with earlier-stage breast cancer may be able to spend less time on hormonal therapy without dimming their prognosis, a new study suggests. In a trial of nearly 3,500 patients, researchers found that seven years of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 7, 2017 Category: General Medicine Source Type: news

Thyroid hormone therapy heals lung fibrosis in animal study
In addition to a promising new treatment for the deadly lung disease, the new research offers unexpected insight into how fibrosis works on a cellular level. (Source: Yale Science and Health News)
Source: Yale Science and Health News - December 4, 2017 Category: Universities & Medical Training Source Type: news

Breast cancer patients don't trust the system and want better treatment, according to new study
(Natural News) A growing number of breast cancer patients are beginning to trust their own instincts and go against their doctor’s advice. In a new survey, nearly one third of women with breast cancer chose to forgo the full, recommended course of chemotherapy, radiation, or hormone therapy, post-surgery. Health authorities find this troubling because “treatment... (Source: NaturalNews.com)
Source: NaturalNews.com - December 1, 2017 Category: Consumer Health News Source Type: news

Hormone therapy after menopause not linked to stroke risk
Women who undergo hormone therapy after menopause are not at higher risk of stroke, research published in the journalPLOS Medicine suggests.Psych Central (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 27, 2017 Category: Endocrinology Source Type: news

Risk of breast cancer recurrence lasts for decades
(Reuters Health) - Many women who follow initial breast cancer treatment with five years of hormone therapy to keep tumors at bay may still experience new malignancies up to two decades after their diagnosis, a study suggests. (Source: Reuters: Health)
Source: Reuters: Health - November 17, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Stopping HRT after menopause may increase cardiovascular disease risk
Research published inMenopause reports that women who stop hormone therapy after menopause are at higher risk of cardiac and stroke death.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 17, 2017 Category: Endocrinology Source Type: news

CV Deaths in Younger Women Rise During Year After Stopping HT CV Deaths in Younger Women Rise During Year After Stopping HT
Women younger than 60 years had a higher risk for cardiac and stroke death during the first year after stopping hormone therapy compared with those not taking HT and those continuing HT, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 16, 2017 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

Oncotarget: Researchers identify potential therapeutic target in aggressive breast cancer cells
(Rapamycin Press) An especially aggressive breast cancer cell can respond to hormone therapy if they express a specific protein known as estrogen receptor beta, according to research published in Oncotarget. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Risk of breast cancer recurring persists after end of hormone therapy
According to a study, published in theNew England Journal of Medicine, women successfully treated for breast cancer with hormone therapy still have an increased risk of it returning, even 15 years after hormone therapy ended.Newsweek  (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 10, 2017 Category: Endocrinology Source Type: news

Growth-hormone Therapy Does Not Raise Heart Risks in Adulthood Growth-hormone Therapy Does Not Raise Heart Risks in Adulthood
Growth-hormone treatment during childhood does not increase young adults ’ cardiovascular disease (CVD) risk, but it improves their lipid profiles, according to industry-funded research.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 9, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Breast cancer 'can return 15 years after treatment ends'
Extending treatment with hormone therapy could reduce the risk of it recurring. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 9, 2017 Category: Consumer Health News Source Type: news

Stopping hormone therapy increases risk of cardiac complications
According to a study, published inMenopause, discontinuing hormone therapy increases the risk of heart–related complications and stroke.News Medical (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 9, 2017 Category: Endocrinology Source Type: news

Risk of cardiac and stroke death increases after discontinuing hormone therapy
(The North American Menopause Society (NAMS)) Hormone therapy (HT) continues to be a hotly debated topic. The benefits of estrogen to the heart, however, appear to be universally accepted. A new study demonstrates that the risk of cardiac and stroke death actually increases in the first year after discontinuation of HT. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2017 Category: International Medicine & Public Health Source Type: news

Hormone Therapy for Menopausal Women in Primary Care Hormone Therapy for Menopausal Women in Primary Care
A better understanding of menopausal hormone therapy will help primary care providers adequately counsel and treat women suffering from vasomotor symptoms.Journal for Nurse Practitioners (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 6, 2017 Category: Consumer Health News Tags: Nursing Journal Article Source Type: news